Neuropsychological functioning in patients with alcohol-related liver disease before and after liver transplantation

Transplantation

Volumn 92, Issue 12, 2011, Pages 1371-1377

  Pegum, Nell ^a,b   Connor, Jason P ^a,b   Feeney, Gerald F X ^a,b   Young, Ross McD ^a,b,c  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Alcoholic liver disease; Cognitive function; Liver transplantation; Reliable Change Index

Indexed keywords

ADULT; ALCOHOL LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; LIVER TRANSPLANTATION; MALE; MENTAL PERFORMANCE; NEUROPSYCHOLOGY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; TASK PERFORMANCE; TREATMENT RESPONSE; VISUOMOTOR COORDINATION; WECHSLER MEMORY SCALE; ALLOTRANSPLANTATION; ARTICLE; ATTENTION; COGNITION; INTELLIGENCE TEST; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT;

ATTENTION; COGNITION; FEMALE; HUMANS; INTELLIGENCE TESTS; LIVER DISEASES, ALCOHOLIC; LIVER TRANSPLANTATION; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84858389825     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182375881     Document Type: Review

References (43)

1. Anantharaju A, Van Thiel DH. Liver transplantation for alcoholic liver disease. Alcohol Res Health 2003; 27: 257.
2. Australian Bureau of Statistics 2008; 3303.0-Causes of Death, Canberra, Australia 2006.
3. Georgiou G, Webb K, Griggs K, et al. First report of a psychosocial intervention for patients with alcohol-related liver disease undergoing liver transplantation. Liver Transpl 2003; 9: 772.
4. Jowsey SG, Taylor ML, Schneekloth TD, et al. Psychosocial challenges in transplantation. J Psychiatr Pract 2001; 7: 404.
5. Bates ME, Bowden SC, Barry D. Neurocognitive impairment associated with alcohol use disorders: Implications for treatment. Exp Clin Psychopharmacol 2002; 10: 193.
6. Chanraud S, Martelli C, Delain F, et al. Brain morphometry and cognitive performance in detoxified alcohol-dependents with preserved psychosocial functioning. Neuropsychopharmacology 2007; 32: 429.
7. Crews FT, Buckley T, Dodd PR, et al. Alcoholic neurobiology: Changes in dependence and recovery. Alcohol Clin Exp Res 2005; 29: 1504.
8. Ratti MT, Bo P, Giardinai A, et al. Chronic alcoholism and the frontal lobe: Which executive functions are impaired? Acta Neurol Scand 2002; 105: 276.
9. Sullivan EV, Fama R, Rosenbloom MJ, et al. A profile of neuropsychological deficits in alcoholic women. Neuropsychology 2002; 16: 74.
10. Harper C, Matsumoto I. Ethanol and brain damage. Curr Opin Pharmacol 2005; 5: 73.
11. Sullivan EV, Rosenbloom MJ, Pfefferbaum A. Pattern of motor and cognitive deficits in detoxified alcoholic men. Alcohol Clin Exp Res 2000; 24: 611.
12. Lezak MD, Howieson DB, Loring D. Neuropsychological assessment [ed. 4]. New York, Oxford 2004.
13. Oscar-Berman M, Marinkovic K. Alcohol. In: Kalechstein A, Van Gorp WG, eds. Neuropsychology and substance use. New York, Taylor & Francis 2007, pp 43-75.
14. Oscar-Berman M, Marinković K. Alcohol: Effects on neurobehavioural functions and the brain. Neuropsychol Rev 2007; 17: 239.
15. Edwin D, Flynn L, Klein A, et al. Cognitive impairment in alcoholic and nonalcoholic cirrhotic patients. Hepatology 1999; 30: 1363.
16. Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy- Definition, nomenclature, diagnosis and quantification: Final report of the working party at the 11th World Congresses of Gatroenterology, Vienna, 1998. Hepatology 2002; 35: 716.
17. Lewis MB, Howdle PD. Cognitive dysfunction and health-related quality of life in long-term liver transplant survivors. Liver Transpl 2003; 9: 1145.
18. Malaguarnera M, Greco F, Barone G, et al. Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: A randomized, double-blind, placebo-controlled study. Dig Dis Sci 2007; 52: 3259.
19. McCrea M, Cordoba J, Vessey G, et al. Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Arch Neurol 1996; 53: 758.
20. Mooney S, Hasssanein TI, Hilsabeck RC, et al. Utility of the repeatable battery for the assessment of neuropsychological status (RBANS) in patients with end-stage liver disease awaiting liver transplant. Arch Clin Neuropsychol 2007; 22: 175.
21. Schomerus H, Hamster W. Neuropsychological aspects of portal-systemic encephalopathy. Metab Brain Dis 1998; 13: 361.
22. Senzolo M, Amodio P, D'Aloiso MC, et al. Neuropsychological and neurophysiological evaluation in cirrhotic patients with minimal hepatic encephalopathy undergoing liver transplantation. Transplant Proc 2005; 37: 1104.
23. Sorrell JH, Zolnikov BJ, Sharma A, et al. Cognitive impairment in people diagnosed with end-stage liver disease evaluated for liver transplantation. Psychiatry Clin Neurosci 2006; 60: 174.
24. Tarter RE, Van Thiel D. Neuropsychological dysfunction due to liver disease. In: Tarter RE, Butters M, Beers SR, eds. Medical neuropsychology [ed. 2]. New York, Kluwer 2001, pp 85-105.
25. Weissenborn K, Heidenreich S, Ennen J, et al. Attention deficits in minimal hepatic encephalopathy. Metab Brain Dis 2001; 16: 13.
26. Weissenborn K, Heidenreich S, Giewekemeyer K, et al. Memory function in early hepatic encephalopathy. J Hepatol 2003; 39: 320.
27. Campagna F, Biancardi A, Cillo U, et al. Neurocognitive-neurological complications of liver transplantation: A review. Metab Brain Dis 2010; 25: 115.
28. Miotto EC, Campanholo KR, Machado MA, et al. Cognitive performance and mood in patients on the waiting list for liver transplantation and their relation to the model for end-stage liver disease. Arq Neuropsiquiatr 2010; 68: 62.
29. Meyer T, Eshelman A, Abouljoud M. Neuropsychological changes in a large sample of liver transplant candidates. Transplant Proc 2006; 38: 3559.
30. Bush BA. Psychosocial, emotional and neuropsychologic factors influencing compliance and liver transplant outcomes. Cur Opin Organ Transplant 2004; 9: 104.
31. Mattarozzi K, Stacciari A, Vignatelli L, et al. Minimal hepatic encephalopathy: Longitudinal effects of liver transplantation. Arch Neurol 2004; 61: 242.
32. Moore KA, McL Jones R, Burrows GD. Quality of life and cognitive function of liver transplant patients: A prospective study. Liver Transpl 2000; 6: 633.
33. O'Carroll RE, Couston M, Cossar J, et al. Psychological outcome and quality of life following liver transplantation: A prospective, national, single centre study. Liver Transpl 2003; 9: 712.
34. Riether AM, Smith SL, Lewison BJ, et al. Quality of life changes and psychiatric neurocognitive outcome after heart and liver transplantation. Transplantation 1992; 54: 444.
35. Rovira A, Mínguez B, Aymerich FX, et al. Decreased white matter lesion volume and improved cognitive function after liver transplantation. Hepatology 2007; 46: 1485.
36. Connor JP, Grier M, Feeney GF, et al. The validity of the brief Michigan Alcohol Screening Test (bMAST) as a problem drinking severity measure. J Stud Alcohol Drugs 2007; 68: 771.
37. Pokorny AD, Miller BA, Kaplan HB. The brief MAST: A shortened version of the Michigan Alcoholism Screening Test. Am J Psychiatry 1972; 129: 342.
38. Rowley AA, Hong BA, Chapman W, et al. The psychiatric diagnosis of alcohol abuse and the medical diagnosis of alcoholic related liver disease: Effects on liver transplant survival. J Clin Psychol Med Settings 2010; 17: 195.
39. DiMartini A, Fontes P, Dew MA, et al. Age, model for end-stage liver disease score, and organ functioning predict posttransplant tacrolimus neurotoxicity. Liver Transpl 2008; 14: 815.
40. Varma V, Webb K, Mirza DF. Liver transplantation for alcoholic liver diseases. World J Gastroenterol 2010; 16: 4377.
41. Jacobson NS, Truax P. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991; 59: 12.
42. Evans C, Margison F, Barkham M. The contribution of reliable and clinically significant change methods to evidence-based mental health. Evid Base Ment Health 1998; 1: 70.
43. Devilly GJ. The reliable and clinical change generator for Windows (professional edition): Version 4.0 (computer program). Swinburne University, Australia: The Brain Sciences Institute 2005.